naproxen-D-Phe-D-Phe | 1411586-16-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: naproxen-D-Phe-D-Phe
• 英文别名: (2R)-2-[[(2R)-2-[[(2S)-2-(6-methoxynaphthalen-2-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid
• CAS: 1411586-16-7
• 化学式: C₃₂H₃₂N₂O₅
• 分子量: 524.616
• InChiKey: MERFDCDYJIRLDO-HUXLMHJOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  39
• 可旋转键数：
  11
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  105
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  naproxen-D-Phe-D-Phe 在 sodium carbonate 、 N,N'-二环己基碳二亚胺 、 alkaline phosphatase 作用下， 以 氯仿 、 水 、 丙酮 为溶剂， 反应 27.0h， 生成 naproxen-D-Phe-D-Phe-D-Tyr
  参考文献：
  名称：

  The conjugation of nonsteroidal anti-inflammatory drugs (NSAID) to small peptides for generating multifunctional supramolecular nanofibers/hydrogels

  摘要：

  在这里，我们报告了由非甾体抗炎药（NSAID）和小肽组成的超分子水凝胶剂。Phe–Phe和NSAIDs的共价连接产生了在水溶液中自组装形成分子纳米纤维作为水凝胶基质的偶联物。当NSAID是萘普生（1）时，所得的水凝胶剂1a在pH 7.0的临界浓度（cgc）为0.2 wt%时形成水凝胶。水凝胶剂1a，也作为一种通用结构，能够进行酶促水凝胶化，即前体在生理条件下经磷酸酶催化的水解转变为水凝胶剂。Phe–Phe与其他NSAIDs，如（R）-氟比洛芬（2）、消旋氟比洛芬（3）和消旋布洛芬（4）的偶联物能够形成分子水凝胶，但在阿司匹林（5）的情况下则不能。与小肽偶联后，NSAIDs对其靶标的选择性得到提高。此外，由D-氨基酸组成的小肽有助于保持NSAIDs的活性。除了证明常见的NSAIDs是促进水溶液中芳香族-芳香族相互作用以形成水凝胶的优秀候选者外，这项工作还促进了具有双重或多重功能的功能分子的发展，并最终可能导致用于外用治疗剂的新型分子水凝胶的产生。

  DOI：

  10.3762/bjoc.9.104
• 作为产物：
  描述：

  萘普生 在 sodium carbonate 、 N,N'-二环己基碳二亚胺 作用下， 以 氯仿 、 水 、 丙酮 为溶剂， 反应 26.0h， 生成 naproxen-D-Phe-D-Phe
  参考文献：
  名称：

  The conjugation of nonsteroidal anti-inflammatory drugs (NSAID) to small peptides for generating multifunctional supramolecular nanofibers/hydrogels

  摘要：

  在这里，我们报告了由非甾体抗炎药（NSAID）和小肽组成的超分子水凝胶剂。Phe–Phe和NSAIDs的共价连接产生了在水溶液中自组装形成分子纳米纤维作为水凝胶基质的偶联物。当NSAID是萘普生（1）时，所得的水凝胶剂1a在pH 7.0的临界浓度（cgc）为0.2 wt%时形成水凝胶。水凝胶剂1a，也作为一种通用结构，能够进行酶促水凝胶化，即前体在生理条件下经磷酸酶催化的水解转变为水凝胶剂。Phe–Phe与其他NSAIDs，如（R）-氟比洛芬（2）、消旋氟比洛芬（3）和消旋布洛芬（4）的偶联物能够形成分子水凝胶，但在阿司匹林（5）的情况下则不能。与小肽偶联后，NSAIDs对其靶标的选择性得到提高。此外，由D-氨基酸组成的小肽有助于保持NSAIDs的活性。除了证明常见的NSAIDs是促进水溶液中芳香族-芳香族相互作用以形成水凝胶的优秀候选者外，这项工作还促进了具有双重或多重功能的功能分子的发展，并最终可能导致用于外用治疗剂的新型分子水凝胶的产生。

  DOI：

  10.3762/bjoc.9.104

文献信息

• [EN] HYDROGELATORS COMPRISING D-AMINO ACIDS<br/>[FR] COMPOSÉS FORMANT DES HYDROGELS COMPRENANT DES ACIDES AMINÉS D
  申请人：UNIV BRANDEIS

  公开号：WO2014074789A1

  公开（公告）日：2014-05-15

  Described herein are compounds comprising an oligopeptide and a non-steroidal antiinflammatory agent. The compounds self-assemble into supramolecular hydrogels and can be used as topical treatments for inflammatory conditions, such as osteoarthritis. Also described herein are oligopeptides compounds made from D-amino acid residues that form supramolecular hydrogels. The compounds may be functionalized with active agents, such as anticancer therapeutic agents, antiinflammatory agents, or imaging agents, therefore providing new mechanisms for delivery of active agents.

  本文描述了包含寡肽和非甾体抗炎药物的化合物。这些化合物自组装成超分子水凝胶，可用作治疗炎症病症，如骨关节炎的局部治疗。本文还描述了由D-氨基酸残基制成的寡肽化合物，形成超分子水凝胶。这些化合物可以与活性剂（如抗癌治疗剂、抗炎药物或成像剂）功能化，从而提供了传递活性剂的新机制。
• HYDROGELATORS COMPRISING D-AMINO ACIDS
  申请人：BRANDEIS UNIVERSITY

  公开号：US20150306232A1

  公开（公告）日：2015-10-29

  Described herein are compounds comprising an oligopeptide and a non-steroidal antiinflammatory agent. The compounds self-assemble into supramolecular hydrogels and can be used as topical treatments for inflammatory conditions, such as osteoarthritis. Also described herein are oligopeptides compounds made from D-amino acid residues that form supramolecular hydrogels. The compounds may be functionalized with active agents, such as anticancer therapeutic agents, antiinflammatory agents, or imaging agents, therefore providing new mechanisms for delivery of active agents.

  本文描述了包含寡肽和非甾体抗炎药物的化合物。这些化合物自组装成超分子水凝胶，并可用作局部治疗炎症疾病，如骨关节炎。本文还描述了由D-氨基酸残基制成的寡肽化合物，形成超分子水凝胶。这些化合物可与活性剂（如抗癌治疗剂、抗炎剂或成像剂）功能化，因此提供了新的活性剂传递机制。
• <scp>d</scp>-Amino Acids Boost the Selectivity and Confer Supramolecular Hydrogels of a Nonsteroidal Anti-Inflammatory Drug (NSAID)
  作者：Jiayang Li、Yi Kuang、Yuan Gao、Xuewen Du、Junfeng Shi、Bing Xu

  DOI：10.1021/ja310019x

  日期：2013.1.16

  As systemically used therapeutics for treating acute or chronic pains or inflammations, nonsteroidal anti-inflammatory drugs (NSAIDs) also associate with the adverse gastrointestinal and renal effects and cardiovascular risks. Thus, it is beneficial to develop topical gels that selectively inhibit cyclooxygenase-2 (COX-2) for the management of local inflammation. In this work, we demonstrate that the covalent conjugation of D-amino acids to naproxen (i.e., a NSAID) not only affords supramolecular hydrogelators for the topical gels but also unexpectedly and significantly elevates the selectivity toward COX-2 about 20X at little expense of the activity of naproxen. This work illustrates a previously unexplored approach that employs D-amino acids for the development of functional molecules that have dual or multiple roles and exceptional biostability, which offers a new class of molecular hydrogels of therapeutic agents.
• The conjugation of nonsteroidal anti-inflammatory drugs (NSAID) to small peptides for generating multifunctional supramolecular nanofibers/hydrogels
  作者：Jiayang Li、Yi Kuang、Junfeng Shi、Yuan Gao、Jie Zhou、Bing Xu

  DOI：10.3762/bjoc.9.104

  日期：——

  Here we report supramolecular hydrogelators made of nonsteroidal anti-inflammatory drugs (NSAID) and small peptides. The covalent linkage of Phe–Phe and NSAIDs results in conjugates that self-assemble in water to form molecular nanofibers as the matrices of hydrogels. When the NSAID is naproxen (1), the resultant hydrogelator 1a forms a hydrogel at a critical concentration (cgc) of 0.2 wt % at pH 7.0. Hydrogelator 1a, also acting as a general motif, enables enzymatic hydrogelation in which the precursor turns into a hydrogelator upon hydrolysis catalyzed by a phosphatase at physiological conditions. The conjugates of Phe–Phe with other NSAIDs, such as (R)-flurbiprofen (2), racemic flurbiprofen (3), and racemic ibuprofen (4), are able to form molecular hydrogels, except in the case of aspirin (5). After the conjugation with the small peptides, NSAIDs exhibit improved selectivity to their targets. In addition, the peptides made of D-amino acids help preserve the activities of NSAIDs. Besides demonstrating that common NSAIDs are excellent candidates to promote aromatic–aromatic interaction in water to form hydrogels, this work contributes to the development of functional molecules that have dual or multiple roles and ultimately may lead to new molecular hydrogels of therapeutic agents for topical use.

  在这里，我们报告了由非甾体抗炎药（NSAID）和小肽组成的超分子水凝胶剂。Phe–Phe和NSAIDs的共价连接产生了在水溶液中自组装形成分子纳米纤维作为水凝胶基质的偶联物。当NSAID是萘普生（1）时，所得的水凝胶剂1a在pH 7.0的临界浓度（cgc）为0.2 wt%时形成水凝胶。水凝胶剂1a，也作为一种通用结构，能够进行酶促水凝胶化，即前体在生理条件下经磷酸酶催化的水解转变为水凝胶剂。Phe–Phe与其他NSAIDs，如（R）-氟比洛芬（2）、消旋氟比洛芬（3）和消旋布洛芬（4）的偶联物能够形成分子水凝胶，但在阿司匹林（5）的情况下则不能。与小肽偶联后，NSAIDs对其靶标的选择性得到提高。此外，由D-氨基酸组成的小肽有助于保持NSAIDs的活性。除了证明常见的NSAIDs是促进水溶液中芳香族-芳香族相互作用以形成水凝胶的优秀候选者外，这项工作还促进了具有双重或多重功能的功能分子的发展，并最终可能导致用于外用治疗剂的新型分子水凝胶的产生。